If l took a guess at our program it would be Phase 2 results being filtering in over the next 4/12 months, if the results are as predicted or close to. That would put us in a position to be exploring licensing agreements follows by injections of funds from them and then commercialisation, l believe with the results from Phase 1 it unlikely the FDA will request us to engage in Phase 3. l think we are looking good at this stage with our patients and investments.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.23M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 319437 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 48681 | 1 |
View Market Depth
| Last trade - 09.41am 30/07/2025 (20 minute delay) ? |
| PTX (ASX) Chart |
Day chart unavailable